Z-0590-2024 Class II Ongoing

Recalled by LEICA BIOSYSTEMS NUSSLOCH GMBH — Nussloch, N/A

FDA device recall Z-0590-2024 was initiated by LEICA BIOSYSTEMS NUSSLOCH GMBH on Nov 20, 2023 and is designated Class II. Reason for recall: There is an issue regarding poorly processed and/or damaged biopsy tissue specimens on the HistoCore PEGASUS / HistoCore PEGASUS Plus resulting from an incorrect assignment of the carryover value set… The recall status is ongoing. Affected quantity: 98 devices.

Recall details

Product Type
Devices
Report Date
May 1, 2024
Initiation Date
Nov 20, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
98 devices

Product description

Leica HistoCore PEGASUS (PROCESSOR, TISSUE, AUTOMATED)

Reason for recall

There is an issue regarding poorly processed and/or damaged biopsy tissue specimens on the HistoCore PEGASUS / HistoCore PEGASUS Plus resulting from an incorrect assignment of the carryover value set for created or edited protocols.

Distribution pattern

US, Nationwide

Code information

All devices with serial number: G0061-G0701

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0590-2024
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0590-2024. Report a data issue: hello@regdatalab.com.